Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest BD Stories

2014-04-03 08:29:53

FRANKLIN LAKES, N.J., April 3, 2014 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its second fiscal quarter 2014 earnings conference call on Thursday, May 1, 2014, at 8:00 a.m. (ET). BD will issue a press release detailing the quarter's earnings earlier that morning. The webcast of the conference call, along with related slides, will be accessible through BD's website at www.bd.com/investors and will be available...

2014-03-24 16:24:17

Global Expert on Infectious Disease and Public Health FRANKLIN LAKES, N.J., March 24, 2014 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced the election of Dr. Claire Pomeroy to its Board of Directors. Dr. Pomeroy, 58, is an expert in infectious diseases and a long-time advocate for public health and patients, especially those with HIV/AIDS. She is currently President of the Albert and Mary Lasker Foundation, a...

2014-03-19 08:29:00

BD Veritor(TM) System for Rapid Detection of RSV Receives 510(k) Clearance and CLIA Waiver FRANKLIN LAKES, N.J., March 19, 2014 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it received 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver from the U.S. Food and Drug Administration (FDA) for nasopharyngeal swab specimens on the BD Veritor(TM) System...

2014-02-25 08:32:06

BD Veritor(TM) System for Rapid Detection of Group A Strep Receives 510(k) Clearance and CLIA Waiver FRANKLIN LAKES, N.J., Feb. 25, 2014 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it received 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) Waiver from the U.S. Food and Drug Administration (FDA) for the BD Veritor(TM) System for Rapid Detection of...

2014-02-25 08:32:04

FRANKLIN LAKES, N.J., Feb. 25, 2014 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the following investor healthcare conferences in March 2014: Raymond James 35(th) Annual Institutional Investors ConferenceMarch 3, 20141:05 p.m. ET Cowen and Company 34(th) Annual Healthcare ConferenceMarch 5, 201411:20 a.m. ET Live webcasts of BD's presentations can be accessed on the BD corporate...

2014-02-12 08:34:29

TORRANCE, Calif., Feb. 12, 2014 /PRNewswire/ -- For the second year in a row, Agile-1, a global workforce management solutions company, received recognition from BD (Becton, Dickinson and Company), a leading global medical technology company, for providing exceptional performance. This year's award, Process Innovation - Regional Supplier of the Year, is based on Agile-1's superior performance, continuous improvement and customer service. Partnering with clients to help them achieve...

2014-02-07 16:24:53

FRANKLIN LAKES, N.J., Feb. 7, 2014 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following investor healthcare conferences in February 2014: Leerink Global Healthcare Conference 2014February 12, 201410:15 a.m. ET Citi 2014 Global Healthcare ConferenceFebruary 25, 201412:15 p.m. ET Live webcasts of BD's presentations can be accessed on the BD corporate website at...

2014-02-07 12:23:23

FRANKLIN LAKES, N.J., Feb. 7, 2014 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global technology company, today announced the appointment of Amit Bhalla as Vice President, Global Strategy and Development. Mr. Bhalla will join BD in March, 2014 and will report to Vincent A. Forlenza, Chairman, Chief Executive Officer and President. "I am pleased to welcome Amit to our management team," said Mr. Forlenza. "His extensive experience covering the Medical...

2014-01-28 16:25:19

FRANKLIN LAKES, N.J., Jan. 28, 2014 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 54.5 cents per common share payable on March 31, 2014 to holders of record on March 10, 2014. The indicated annual dividend rate is $2.18 per share. About BDBD is a leading medical technology company that partners with customers and stakeholders to address many of the world's most pressing and evolving health needs. Our...

2014-01-14 08:29:20

FRANKLIN LAKES, N.J., Jan. 14, 2014 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 28, 2014, at 1 p.m. (ET). The webcast can be accessed from the BD corporate website at http://www.bd.com/investors and will be available for replay through Tuesday, February 4, 2014. About BDBD is a leading medical technology company that...